BiotechTube
Home/Elute, Inc/David W. Grainger, Ph.D.
DW

David W. Grainger, Ph.D.

Co-founder, Chief Science Officer

Elute, Inc

Therapeutic Areas

OrthopedicsInfectious Disease

Elute, Inc Pipeline

DrugIndicationPhase
BonVie+™ (EP Granules with Tobramycin)Periprosthetic Joint Infection (PJI) in two-stage revision surgeryPhase 2/3

Leadership Team at Elute, Inc

DF
Denny Farrar
Co-founder, Executive Chairman
AC
Ashok C. Khandkar, Ph.D.
President & CEO
View full Elute, Inc profile